High-affinity neuropeptide Y receptor antagonists.

AUTOR(ES)

Daniels, A J

RESUMO

Neuropeptide Y (NPY) is one of the most abundant peptide transmitters in the mammalian brain. In the periphery it is costored and coreleased with norepinephrine from sympathetic nerve terminals. However, the physiological functions of this peptide remain unclear because of the absence of specific high-affinity receptor antagonists. Three potent NPY receptor antagonists were synthesized and tested for their biological activity in in vitro, ex vivo, and in vivo functional assays. We describe here the effects of these antagonists inhibiting specific radiolabeled NPY binding at Y1 and Y2 receptors and antagonizing the effects of NPY in human erythroleukemia cell intracellular calcium mobilization perfusion pressure in the isolated rat kidney, and mean arterial blood pressure in anesthetized rats.

Documentos Relacionados

• High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.
• Assembly of high-affinity insulin receptor agonists and antagonists from peptide building blocks
• Stable “zeta” peptides that act as potent antagonists of the high-affinity IgE receptor
• Physical association between the high-affinity IgG receptor (Fc gamma RI) and the gamma subunit of the high-affinity IgE receptor (Fc epsilon RI gamma).
• Properties of a high-affinity DNA binding site for estrogen receptor.